Michael C Milone

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 7

Top Venues

Blood cancer discovery

Nature cancer

Science (New York, N.Y.)

Nature biomedical engineering

University of Pennsylvania

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Jul 01 2007

United States

Associate Professor :: Pathology & Laboratory Medicine

Publications

Hongru Zhang, Pengfei Yu, Vivek S Tomar, Xiangjie Chen, Matthew J Atherton, Zhen Lu, Hong-Guang Zhang, Shifeng Li, Angelica Ortiz, Jun Gui, N Adrian Leu, Fangxue Yan, Andres Blanco, Mirella L Meyer-Ficca, Ralph G Meyer, Daniel P Beiting, Jinyang Li, Selene Nunez-Cruz, Roddy S O'Connor, Lexus R Johnson, Andy J Minn, Subin S George, Constantinos Koumenis, J Alan Diehl, Michael C Milone, Hui Zheng, Serge Y Fuchs
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors. Nature cancer 3 (7) (2022)
Saba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, Jai Patel, John Leferovich, Marilia Pinzone, Feng Shen, Katherine D Cummins, Gabriela Plesa, Vito Adrian Cantu, Shantan Reddy, Frederic D Bushman, Saar I Gill, Una O'Doherty, Roderick O'Connor, Michael C Milone
Rapid manufacturing of non-activated potent CAR T cells. Nature biomedical engineering 6 (2) (2022)
Alfred L Garfall, Adam David Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Donald L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer
Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood cancer discovery (2022)
Kavita M Dhodapkar, Adam David Cohen, Akhilesh Kaushal, Alfred L Garfall, Renee Julia Manalo, Allison R Carr, Samuel S McCachren, Edward A Stadtmauer, Simon F Lacey, Jan Joseph Melenhorst, Carl H June, Michael C Milone, Madhav V Dhodapkar
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma. Blood cancer discovery 3 (6) (2022)
Qian Zhang, Morgan E Hresko, Lora K Picton, Leon L Su, Michael J Hollander, Selene Nunez-Cruz, Zheng Zhang, Charles-Antoine Assenmacher, Jonathan T Sockolosky, K Christopher Garcia, Michael C Milone
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Science translational medicine 13 (625) (2021)
Carl H June, Roddy S O'Connor, Omkar U Kawalekar, Saba Ghassemi, Michael C Milone
CAR T cell immunotherapy for human cancer. Science (New York, N.Y.) 359 (6382) (2018)
Vijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen A Callahan, Christoph T Ellebrecht, Amrom E Obstfeld, Simon F Lacey, Jan J Melenhorst, Farzana Nazimuddin, Wei-Ting Hwang, Shannon L Maude, Mariusz A Wasik, Adam Bagg, Stephen Schuster, Michael D Feldman, David L Porter, Stephen A Grupp, Carl H June, Michael C Milone
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood 128 (3) (2016)

Michael C Milone.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael C Milone